Ropinirole shortage — BE supply status & alternatives

Ropinirole

—

In supply · Australia

In supply · 🇦🇺 Australia · short in🇨🇦 CA🇫🇷 FR🇧🇪 BE

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Marketing-authorisation holders
Active ingredient (INN)	Ropinirole
Therapeutic category	Auto-created by Agence nationale de sécurité du médicament — Disponibilité scraper
Controlled substance	No

Registrations on file	17

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Other markets

🇬🇧 GB

£10.08

Drug Tariff

🇺🇸 US

US$0.07

Acquisition

🇫🇷 FR

€6.97

Retail price

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

9 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Synthimed Labs Private LTDOrbion Pharmaceuticals Private LTDAlivus Life Sciences LTDDr Reddys Laboratories LTDTorrent Pharmaceuticals LTDUsv Private LTD+3 more

Manufacturing countries: India, China · Source: FDA List of Drug Master Files

Recalls official enforcement reports

🇺🇸

Ropinirole

RemedyRepack Inc. · Mar 2023

Class IIdetails ↗

🇺🇸

Ropinirole

RemedyRepack Inc. · Mar 2023

Class IIdetails ↗

🇺🇸

Ropinirole

Direct Rx · Mar 2023

Class IIdetails ↗

🇺🇸

Ropinirole

Direct Rx · Mar 2023

Class IIdetails ↗

🇺🇸

ROPINIROLE

Accord Healthcare, Inc. · Feb 2023

Class IIdetails ↗

🇺🇸

ROPINIROLE

Accord Healthcare, Inc. · Feb 2023

Class IIdetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders17 registrations · 6 MA holders

Product	Strength	Form	Market	MA holder	Status
ROPINIROLE 0.25 MG FILM-COATED TABLETS	0.25 MG	tablet	🇬🇧 GB	TEVA UK LIMITED	Active
ROPINIROLE 0.5 MG FILM-COATED TABLETS	0.5 MG	tablet	🇬🇧 GB	TEVA UK LIMITED	Active
ROPINIROLE 2 MG FILM-COATED TABLETS	2 MG	tablet	🇬🇧 GB	TEVA UK LIMITED	Active
Ropinirole Krka	2 MG	tablet	🇬🇧 GB	KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO	Active
Ropinirole Krka	4 MG	tablet	🇬🇧 GB	KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO	Active
Ropinirole Krka	8 MG	tablet	🇬🇧 GB	KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO	Active
ROPINIROLE 1MG FILM-COATED TABLETS	1MG	tablet	🇬🇧 GB	Generics (UK) Limited	Active
ROPINIROLE 2MG FILM-COATED TABLETS	2MG	tablet	🇬🇧 GB	Generics (UK) Limited	Active
ROPINIROLE 5 MG FILM-COATED TABLETS	5 MG	tablet	🇬🇧 GB	Generics (UK) Limited	Active
ROPINIROLE 1 MG FILM-COATED TABLETS	1 MG	tablet	🇬🇧 GB	ACCORD HEALTHCARE LIMITED	Active
Ropinirole Sr	2MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
Ropinirole Sr	3MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
Ropinirole Sr	4MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
Ropinirole Sr	8MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
ROPINIROLE 0.25MG FILM-COATED TABLETS	0.25MG	tablet	🇬🇧 GB	GLENMARK PHARMACEUTICALS EUROPE LIMITED	Active

+2 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.